Caribou Biosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,667 | $2,353 | $2,077 | $2,024 |
Gross Profit | 2,667 | 2,353 | 893 | 2,024 |
EBITDA | -34,261 | -41,748 | -34,431 | -38,238 |
EBIT | -35,428 | -42,913 | -35,615 | -39,415 |
Net Income | -54,098 | -39,991 | -35,490 | -34,684 |
Net Change In Cash | 2,667 | 2,353 | 2,077 | 2,024 |
Free Cash Flow | -28,676 | -37,767 | -35,988 | -33,334 |
Cash | 25,201 | 29,417 | 16,293 | 31,970 |
Basic Shares | 93,028 | 92,679 | 90,317 | 90,455 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $9,994 | $34,477 | $13,851 | $9,598 |
Gross Profit | 6,067 | 30,952 | 10,210 | 8,614 |
EBITDA | -166,616 | -112,534 | -104,777 | -65,995 |
EBIT | -170,543 | -116,059 | -106,399 | -66,979 |
Net Income | -149,105 | -102,070 | -99,421 | -66,923 |
Net Change In Cash | 9,994 | 34,477 | 13,851 | 9,598 |
Cost of Revenue | -182,082 | 224,513 | ||
Free Cash Flow | -143,080 | -104,904 | -98,020 | -35,640 |
Cash | 16,293 | 51,162 | 58,338 | 240,420 |
Basic Shares | 90,317 | 73,807 | 60,801 | 60,263 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.35 |
2025-03-31 | -$0.43 |
2024-12-31 | -$0.39 |
